Cancer Research

Tumor Mutation Load Assay 

At Genet, we offer the “Oncomine Tumor Mutation Load Assay,” a cutting-edge service designed to identify cancer driver variants and evaluate tumor mutational burden (TMB), a promising immuno-oncology biomarker, utilizing next-generation sequencing technology. Immune checkpoint […]

Cancer Research

HRR Pathway

The following targets are included in the Oncomine™ HRR Pathway Predesigned Panel:

Cancer Research Applications

Cancer RNA Expression

Transcriptome Human Gene Expression RNA Human Oncology Pathways RNA Breast Cancer Research Panel RNA Cancer Panel RNA Pancreatic Adenocarcinoma Research Panel  RNA MAPK Pathway Research Panel  Long Non-coding RNA Research Panel  RNA WNT Signaling Pathway […]